Cetera Investment Advisers
CSTL icon

Cetera Investment Advisers’s Castle Biosciences CSTL Stock Holding History

Cetera Investment Advisers’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$226K Buy
9,208
+273
+3% +$8.94K ﹤0.01% 4202
2025
Q4 		$348K Buy
+8,935
New +$288K ﹤0.01% 3764

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cetera Investment Advisers's CSTL Position: Q1 2026 in Review

Cetera Investment Advisers increased its Castle Biosciences (CSTL) stake by 3.1% in Q1 2026, buying an estimated $8.94K and bringing the position to 9,208 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #4202.

Cetera Investment Advisers first reported a position in CSTL in Q4 2025 and has held it in 2 quarters since. The position peaked at $348K in Q4 2025. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • Cetera Investment Advisers held 9,208 shares of Castle Biosciences worth $226K as of Q1 2026.
  • Cetera Investment Advisers bought 273 Castle Biosciences shares in Q1 2026, an estimated $8.94K.
  • Castle Biosciences made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #4202 holding.
  • Cetera Investment Advisers first reported a position in Castle Biosciences in Q4 2025 and has held it in 2 quarters since.
  • Cetera Investment Advisers's Castle Biosciences position peaked at $348K in Q4 2025.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.